Trial intelligence / Profile preview

Beta-lactam for bacterial pneumonia

NCT00111644Phase 2Completed

Sponsor
Roche
Start
Mar 2005
Primary completion
Jan 2007
Modality
Small Molecules
Countries
11
01

Overview

Phase 2, randomised, double-blind trial of amoxicillin in bacterial pneumonia (3 arms), sponsored by Roche. Primary endpoint: Clinical cure rate. Started Mar 2005; status: completed.

02

Drugs

amoxicillin
03

Conditions

bacterial pneumonia

Beyond the preview

Go deeper on NCT00111644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00111644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call